source
stringlengths 2
222
| date
stringlengths 19
19
| url
stringlengths 22
853
⌀ | text
stringlengths 0
10k
⌀ | title
stringlengths 0
701
| context_id
stringlengths 1
9
| document_id
stringclasses 2
values | document_type
stringclasses 2
values |
|---|---|---|---|---|---|---|---|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-10 08:00:00
| null |
ENCRYPTION-BASED THREATS GROW BY 260% IN 2020
|
NEW RESEARCH SHOWS ATTACKERS TURNING TO ENCRYPTED ATTACKS DURING PANDEMIC
|
ZS
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-09-09 19:30:00
| null |
ZSCALER REPORTS FOURTH QUARTER AND FISCAL 2020 FINANCIAL RESULTS.Q4 NON-GAAP EARNINGS PER SHARE $0.05.Q4 REVENUE $125.9 MILLION VERSUS REFINITIV IBES ESTIMATE OF $118.5 MILLION.Q4 EARNINGS PER SHARE ESTIMATE $0.03 -- REFINITIV IBES DATA.QTRLY GAAP NET LOSS PER SHARE WAS $0.38.SEES Q1 2021 TOTAL REVENUE OF $131 MILLION TO $133 MILLION.SEES Q1 2021 NON-GAAP EARNINGS PER SHARE OF APPROXIMATELY $0.05 TO $0.06.SEES FY 2021 TOTAL REVENUE OF $580 MILLION TO $590 MILLION.SEES FY 2021 NON-GAAP EARNINGS PER SHARE OF $0.28 TO $0.30.SEES FY2021 CALCULATED BILLINGS OF $710 MILLION TO $720 MILLION.Q1 EARNINGS PER SHARE VIEW $0.03, REVENUE VIEW $126.6 MILLION -- REFINITIV IBES DATA.FY2021 EARNINGS PER SHARE VIEW $0.29, REVENUE VIEW $557.8 MILLION -- REFINITIV IBES DATA.
|
ZSCALER REPORTS Q4 NON-GAAP EARNINGS PER SHARE $0.05
|
ZS
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-06-23 09:30:00
| null |
ZSCALER ANNOUNCES PRICING OF $1.0 BILLION OFFERING 0.125% CONVERTIBLE SENIOR NOTES DUE 2025.
|
ZSCALER ANNOUNCES PRICING OF $1.0 BLN OFFERING 0.125% CONVERTIBLE SENIOR NOTES DUE 2025
|
ZS
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-06-22 12:30:00
| null |
ZSCALER ANNOUNCES PROPOSED OFFERING OF $1.0 BILLION OF CONVERTIBLE SENIOR NOTES DUE 2025.
|
ZSCALER ANNOUNCES PROPOSED OFFERING OF $1.0 BLN OF CONVERTIBLE SENIOR NOTES DUE 2025
|
ZS
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-05-28 19:30:00
| null |
ZSCALER REPORTS THIRD QUARTER FISCAL 2020 FINANCIAL RESULTS.Q3 NON-GAAP EARNINGS PER SHARE $0.07.Q3 REVENUE $110.5 MILLION VERSUS REFINITIV IBES ESTIMATE OF $106.4 MILLION.Q3 EARNINGS PER SHARE ESTIMATE $0.02 -- REFINITIV IBES DATA.SEES Q4 OF FISCAL 2020 TOTAL REVENUE OF $117 MILLION TO $119 MILLION.SEES Q4 OF FISCAL 2020 NON-GAAP EARNINGS PER SHARE OF APPROXIMATELY $0.02 TO $0.03.SEES FULL YEAR FISCAL 2020 TOTAL REVENUE OF $422 MILLION TO $424 MILLION.SEES FULL YEAR FISCAL 2020 CALCULATED BILLINGS OF $529 MILLION TO $531 MILLION.SEES FULL YEAR FISCAL 2020 NON-GAAP EARNINGS PER SHARE OF $0.20 TO $0.21.Q4 EARNINGS PER SHARE VIEW $0.01, REVENUE VIEW $114.4 MILLION -- REFINITIV IBES DATA.FY2020 EARNINGS PER SHARE VIEW $0.15, REVENUE VIEW $416.0 MILLION -- REFINITIV IBES DATA.
|
ZSCALER Q3 ADJUSTED EARNINGS PER SHARE $0.07
|
ZS
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-04-09 10:30:00
| null |
ZSCALER ANNOUNCES INTENT TO ACQUIRE CLOUDNEETI.ZSCALER INC SAYS TERMS OF TRANSACTION WERE NOT DISCLOSED.
|
ZSCALER ANNOUNCES INTENT TO ACQUIRE CLOUDNEETI
|
ZS
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-02-20 19:30:00
| null |
ZSCALER REPORTS SECOND QUARTER FISCAL 2020 FINANCIAL RESULTS.Q2 NON-GAAP EARNINGS PER SHARE $0.09.Q2 REVENUE $101.3 MILLION VERSUS REFINITIV IBES ESTIMATE OF $99 MILLION.Q2 EARNINGS PER SHARE ESTIMATE $0.03 -- REFINITIV IBES DATA.Q2 CALCULATED BILLINGS GROW 18% YEAR-OVER-YEAR TO $135.4 MILLION.Q2 DEFERRED REVENUE GROWS 36% YEAR-OVER-YEAR TO $280.0 MILLION.SEES Q3 TOTAL REVENUE OF $105 MILLION TO $107 MILLION.SEES Q3 NON-GAAP INCOME FROM OPERATIONS OF $1 MILLION TO $3 MILLION.SEES Q3 NON-GAAP EARNINGS PER SHARE OF APPROXIMATELY $0.01 TO $0.03.SEES 2020 TOTAL REVENUE OF $414 MILLION TO $417 MILLION.SEES 2020 CALCULATED BILLINGS OF $512 MILLION TO $517 MILLION.SEES 2020 NON-GAAP INCOME FROM OPERATIONS OF $16 MILLION TO $18 MILLION.SEES 2020 NON-GAAP EARNINGS PER SHARE OF $0.14 TO $0.16.Q3 REVENUE VIEW $104.6 MILLION -- REFINITIV IBES DATA.Q3 EARNINGS PER SHARE VIEW $0.04 -- REFINITIV IBES DATA.FY2020 REVENUE VIEW $410.3 MILLION -- REFINITIV IBES DATA.FY2020 EARNINGS PER SHARE VIEW $0.15 -- REFINITIV IBES DATA.
|
ZSCALER REPORTS Q2 NON-GAAP EARNINGS PER SHARE $0.09
|
ZS
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-12-02 22:30:00
| null |
ZSCALER, INC. PROVIDED REVENUE GUIDANCE FOR THE SECOND QUARTER AND FULL FISCAL YEAR 2020. FOR THE SECOND QUARTER, THE COMPANY EXPECTS REVENUE IN THE RANGE OF $97 MILLION TO $100 MILLION, REFLECTING THE YEAR-OVER-YEAR GROWTH OF 31% TO 35%. EXCLUDING THIS REVENUE FROM LAST YEAR, GUIDANCE REFLECTS 35% TO 39% GROWTH. OPERATING PROFIT IN THE RANGE OF $3 MILLION TO $4 MILLION; INCOME TAXES OF $900,000; AND EARNINGS PER SHARE OF APPROXIMATELY $0.03, ASSUMING 138 MILLION COMMON SHARES OUTSTANDING.FOR THE FULL YEAR FISCAL 2020, THE COMPANY EXPECTS REVENUE IN THE RANGE OF $405 MILLION TO $413 MILLION OR YEAR-OVER-YEAR GROWTH OF 34% TO 36%. CALCULATED BILLINGS IN THE RANGE OF $500 MILLION TO $510 MILLION OR YEAR-OVER-YEAR GROWTH OF 28% TO 31%. OPERATING PROFIT IN THE RANGE OF $15 MILLION TO $18 MILLION. THE COMPANY EXPECTS THE COST OF THESE 2 EVENTS TO BE IN THE RANGE OF $5 MILLION TO $6 MILLION; INCOME TAXES OF $3.6 MILLION; AND EARNINGS PER SHARE IN THE RANGE OF $0.13 TO $0.15, ASSUMING APPROXIMATELY 139 MILLION COMMON SHARES OUTSTANDING.
|
ZSCALER, INC. PROVIDES REVENUE GUIDANCE FOR THE SECOND QUARTER AND FULL FISCAL YEAR 2020
|
ZS
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-19 22:30:00
| null |
ZSCALER, INC. PRESENTS AT EVANTA BOSTON CIO EXECUTIVE SUMMIT, NOV-21-2019 09:20 AM. VENUE: THE WESTIN COPLEY PLACE, 10 HUNTINGTON AVE., BOSTON, MASSACHUSETTS, UNITED STATES. SPEAKERS: LISA LORENZIN, DIRECTOR OF TRANSFORMATION STRATEGY.
|
ZSCALER, INC. PRESENTS AT EVANTA BOSTON CIO EXECUTIVE SUMMIT, NOV-21-2019 09:20 AM
|
ZS
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-11 22:30:00
| null |
ZSCALER, INC. ANNOUNCED ZSCALER PRIVATE ACCESS (ZPA), A ZERO TRUST NETWORK ACCESS SERVICE, ACHIEVED FEDERAL RISK AND AUTHORIZATION MANAGEMENT PROGRAM (FEDRAMP) READY STATUS AT THE HIGH IMPACT LEVEL; ENABLING FEDERAL AGENCIES TO USE MODERN AND EMERGING TECHNOLOGIES, LIKE ZSCALER TO MEET THEIR TRUSTED INTERNET CONNECTION (TIC) INITIATIVE REQUIREMENTS. THE ACHIEVEMENT OF FEDRAMP READY AT THE HIGH IMPACT LEVEL INDICATES TO THE FEDERAL GOVERNMENT THAT ZSCALER PRIVATE ACCESS HAS UNDERGONE A RIGOROUS IN-DEPTH AUDIT OF CRITICAL SECURITY CONTROLS TO PROTECT THE GOVERNMENT’S MOST SENSITIVE UNCLASSIFIED DATA IN CLOUD COMPUTING ENVIRONMENTS. THE MILESTONE IS AN IMPORTANT STEP ON ZSCALER’S PATH TO SECURING HIGH BASELINE SYSTEMS AND ACHIEVING DEPARTMENT OF DEFENSE (DOD) IMPACT LEVELS 4, 5, AND 6. THE FEDRAMP READY DESIGNATION EXPANDS THE FEDERAL MARKET FOR ZSCALER, ENABLING ZPA TO MEET THE REQUIREMENTS OF CIVILIAN AGENCIES THAT NEED HIGH BASELINE PLATFORMS AS WELL AS DOD AND INTEL CUSTOMERS. AGENCIES MANAGING DATA IN WHICH LOSS OF CONFIDENTIALITY, INTEGRITY, OR AVAILABILITY COULD BE EXPECTED TO HAVE A SEVERE OR CATASTROPHIC EFFECT ON NATIONAL SECURITY, AGENCY OPERATIONS, ASSETS, OR INDIVIDUALS CAN NOW USE ZPA, A FULLY CLOUD-DELIVERED SERVICE, THAT SECURES ACCESS TO PRIVATE APPLICATIONS WITH ZERO TRUST NETWORK ACCESS (ZTNA). IN ADDITION, ZSCALER’S CLOUD SECURITY PLATFORM MEETS THE NEWLY RELEASED TRUSTED INTERNET CONNECTIONS (TIC) 3.0 POLICY GUIDELINES. TRADITIONAL TIC ARCHITECTURE PREVIOUSLY REQUIRED AGENCIES TO BACKHAUL TRAFFIC, NEGATIVELY IMPACTING SERVICE PERFORMANCE AND AVAILABILITY, HAMPERING MOBILE ACCESS, AND CREATING A ROADBLOCK TO CLOUD DEPLOYMENT. TIC 3.0 GIVES AGENCIES NEW FLEXIBILITY AND THE OPPORTUNITY TO TAKE ADVANTAGE OF CLOUD AND MODERN TECHNOLOGY, SECURELY.
|
ZSCALER, INC.'S ZSCALER PRIVATE ACCESS ACHIEVES FEDRAMP “READY” STATUS AT HIGH IMPACT LEVEL
|
ZS
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-04 22:30:00
| null |
ZSCALER, INC., Q1 2020 EARNINGS CALL, DEC 03, 2019
|
ZSCALER, INC., Q1 2020 EARNINGS CALL, DEC 03, 2019
|
ZS
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-05-13 16:00:00
| null |
FREMONT, CALIF., MAY 13, 2022 (GLOBE NEWSWIRE) -- ZOSANO PHARMA CORPORATION (NASDAQ:ZSAN), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY, TODAY ANNOUNCED FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2022. ALL SHARE AND PER SHARE INFORMATION INCLUDED IN THESE FINANCIAL RESULTS AND STATEMENTS HAS BEEN RETROACTIVELY ADJUSTED TO GIVE EFFECT TO OUR APRIL 11, 2022 1-FOR-35 REVERSE STOCK SPLIT.
|
ZOSANO PHARMA REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-04-29 16:00:00
| null |
FREMONT, CALIF., APRIL 29, 2022 (GLOBE NEWSWIRE) -- ZOSANO PHARMA CORPORATION (NASDAQ:ZSAN), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY, TODAY PROVIDED A CORPORATE UPDATE.
|
ZOSANO PHARMA PROVIDES CORPORATE UPDATE
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-04-11 08:00:00
| null |
ZSAN COMMON STOCK EXPECTED TO BEGIN TRADING ON A SPLIT-ADJUSTED BASIS ON APRIL 12, 2022 ZSAN COMMON STOCK EXPECTED TO BEGIN TRADING ON A SPLIT-ADJUSTED BASIS ON APRIL 12, 2022
|
ZOSANO PHARMA ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE TODAY
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-02-08 21:55:00
| null |
FREMONT, CALIF., FEB. 08, 2022 (GLOBE NEWSWIRE) -- ZOSANO PHARMA CORPORATION (NASDAQ:ZSAN), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY, TODAY ANNOUNCED THE PRICING OF ITS PREVIOUSLY ANNOUNCED UNDERWRITTEN PUBLIC OFFERING OF 51,250,000 UNITS, EACH CONSISTING OF ONE SHARE OF COMMON STOCK AND ONE WARRANT TO PURCHASE ONE SHARE OF COMMON STOCK, AT A PUBLIC OFFERING PRICE OF $0.30 PER UNIT. THE WARRANTS HAVE AN EXERCISE PRICE OF $0.30 PER SHARE, ARE IMMEDIATELY EXERCISABLE AND WILL EXPIRE FIVE YEARS FROM THE DATE OF ISSUANCE. ZOSANO HAS GRANTED THE UNDERWRITER A 30-DAY OPTION TO PURCHASE UP TO AN ADDITIONAL 7,687,500 SHARES OF COMMON STOCK AND/OR ADDITIONAL WARRANTS TO PURCHASE UP TO 7,687,500 SHARES OF COMMON STOCK.
|
ZOSANO PHARMA ANNOUNCES PRICING OF $15.4 MILLION PUBLIC OFFERING OF COMMON STOCK AND WARRANTS
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-02-08 16:10:00
| null |
FREMONT, CALIF., FEB. 08, 2022 (GLOBE NEWSWIRE) -- ZOSANO PHARMA CORPORATION (NASDAQ:ZSAN), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY, TODAY ANNOUNCED THAT IT IS COMMENCING AN UNDERWRITTEN PUBLIC OFFERING OF UNITS CONSISTING OF SHARES OF COMMON STOCK AND WARRANTS TO PURCHASE COMMON STOCK. ALL OF THE UNITS IN THE OFFERING ARE TO BE SOLD BY ZOSANO. THE OFFERING IS SUBJECT TO MARKET AND OTHER CONDITIONS, AND THERE CAN BE NO ASSURANCE AS TO WHETHER OR WHEN THE OFFERING MAY BE COMPLETED, OR THE ACTUAL SIZE OR TERMS OF THE OFFERING.
|
ZOSANO PHARMA ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK AND WARRANTS
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-01-05 12:01:00
| null |
—DATA PUBLISHED IN THE JOURNAL OF VACCINES AND IMMUNOLOGY— —DATA PUBLISHED IN THE JOURNAL OF VACCINES AND IMMUNOLOGY—
|
CORRECTION - ZOSANO PHARMA ANNOUNCES PUBLICATION OF CLINICAL DATA DEMONSTRATING COMPARABLE IMMUNOGENICITY OF A TRIVALENT INFLUENZA VACCINE FORMULATED ON ITS TRANSDERMAL MICRONEEDLE SYSTEM VERSUS AN INTRAMUSCULAR INJECTION OF THE VACCINE AT A HIGHER DOSE
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-01-05 09:20:00
| null |
—DATA PUBLISHED IN THE JOURNAL OF VACCINES AND IMMUNOLOGY— —DATA PUBLISHED IN THE JOURNAL OF VACCINES AND IMMUNOLOGY—
|
ZOSANO PHARMA ANNOUNCES PUBLICATION OF CLINICAL DATA DEMONSTRATING COMPARABLE IMMUNOGENICITY OF A TRIVALENT INFLUENZA VACCINE FORMULATED ON ITS TRANSDERMAL MICRONEEDLE SYSTEM VERSUS AN INTRAMUSCULAR INJECTION OF THE VACCINE AT A HIGHER DOSE
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-12-13 16:30:00
| null |
FREMONT, CALIF., DEC. 13, 2021 (GLOBE NEWSWIRE) -- ZOSANO PHARMA CORPORATION (NASDAQ:ZSAN), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY, TODAY ANNOUNCED CHANGES TO ITS BOARD OF DIRECTORS, INCLUDING THE APPOINTMENT OF ELAINE M. YANG.
|
ZOSANO PHARMA ANNOUNCES CHANGES TO BOARD OF DIRECTORS; APPOINTS CROSS FUNCTIONAL BUSINESS EXECUTIVE ELAINE M. YANG
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-11-29 21:45:00
| null |
FREMONT, CALIF., NOV. 29, 2021 (GLOBE NEWSWIRE) -- ZOSANO PHARMA CORPORATION (NASDAQ:ZSAN), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY, TODAY ANNOUNCED THAT THE BOARD OF DIRECTORS GRANTED A STOCK OPTION TO PURCHASE 220,000 SHARES OF ZOSANO'S COMMON STOCK TO A NEW EMPLOYEE AS AN INDUCEMENT AWARD.
|
ZOSANO PHARMA ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-10-04 08:00:00
| null |
FREMONT, CALIF., OCT. 04, 2021 (GLOBE NEWSWIRE) -- ZOSANO PHARMA CORPORATION (NASDAQ:ZSAN), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY, TODAY ANNOUNCED THE COMPANY HAS BEEN GRANTED A TYPE C WRITTEN RESPONSE ONLY MEETING WITH THE U.S. FOOD AND DRUG ADMINISTRATION (“FDA”) REGARDING THE RESUBMISSION OF THE M207 (ZOLMITRIPTAN TRANSDERMAL MICRONEEDLE SYSTEM) 505(B)(2) NEW DRUG APPLICATION (“NDA”) FOLLOWING RECEIPT OF PRELIMINARY TOP-LINE RESULTS FROM THE PHARMACOKINETIC (“PK”) STUDY.
|
ZOSANO PHARMA GRANTED TYPE C MEETING WITH FDA REGARDING NDA RESUBMISSION FOR M207 FOLLOWING PRELIMINARY TOP-LINE PHARMACOKINETIC STUDY RESULTS
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-09-02 16:30:00
| null |
FREMONT, CALIF., SEPT. 02, 2021 (GLOBE NEWSWIRE) -- ZOSANO PHARMA CORPORATION (NASDAQ:ZSAN), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY, TODAY ANNOUNCED THAT ITS PRESIDENT AND CHIEF EXECUTIVE OFFICER, STEVEN LO, WILL PRESENT A COMPANY OVERVIEW AT THE H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCE AVAILABLE ON DEMAND BEGINNING SEPTEMBER 13, 2021 AT 7:00AM ET.
|
ZOSANO PHARMA TO PRESENT AT THE H.C. WAINWRIGHT VIRTUAL GLOBAL INVESTMENT CONFERENCE
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-07-20 08:30:00
| null |
FREMONT, CALIF., JULY 20, 2021 (GLOBE NEWSWIRE) -- ZOSANO PHARMA CORPORATION (NASDAQ:ZSAN), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY, TODAY ANNOUNCED THAT IT HAS BEEN GRANTED AN ADDITIONAL PATENT COVERING METHOD OF USE OF M207 WITH THE ISSUANCE OF U.S. PATENT NO. 11,058,630 TITLED METHOD OF RAPIDLY ACHIEVING THERAPEUTIC CONCENTRATIONS OF TRIPTANS FOR THE TREATMENT OF MIGRAINES.
|
ZOSANO PHARMA ANNOUNCES ISSUANCE OF U.S. PATENT FOR METHOD OF RAPIDLY ACHIEVING THERAPEUTIC LEVELS WITH M207 FOR THE ACUTE TREATMENT OF MIGRAINE
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-05-26 16:05:00
| null |
FREMONT, CALIF., MAY 26, 2021 (GLOBE NEWSWIRE) -- ZOSANO PHARMA CORPORATION (NASDAQ:ZSAN), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY, TODAY ANNOUNCED THAT AN ARTICLE TITLED, “LONG TERM SAFETY, TOLERABILITY, AND EFFICACY OF INTRACUTANEOUS ZOLMITRIPTAN (M207) IN THE ACUTE TREATMENT OF MIGRAINE” WAS PUBLISHED IN THE JOURNAL OF HEADACHE AND PAIN . THIS OPEN-LABEL, MULTICENTER OBSERVATIONAL STUDY WAS DESIGNED TO EVALUATE THE SAFETY AND EFFICACY OF THE REPEATED USE OF QTRYPTA™ IN ADULTS WITH MIGRAINE WHO HAD HISTORICALLY EXPERIENCED AT LEAST 2 MIGRAINE ATTACKS PER MONTH. THE TOLERABILITY AND EFFICACY RESULTS IN THIS LONG-TERM STUDY WERE CONSISTENT WITH THE RESULTS OBSERVED IN THE PHASE 2/3 ZOTRIP STUDY.
|
ZOSANO PHARMA ANNOUNCES PUBLICATION OF CLINICAL DATA REGARDING THE LONG-TERM USE OF QTRYPTA™ FOR THE TREATMENT OF ACUTE MIGRAINE IN THE JOURNAL OF HEADACHE AND PAIN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-05-25 16:05:00
| null |
FREMONT, CALIF., MAY 25, 2021 (GLOBE NEWSWIRE) -- ZOSANO PHARMA CORPORATION (NASDAQ:ZSAN), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY, TODAY ANNOUNCED THE APPOINTMENT OF KATHY MCGEE, AN ACCOMPLISHED BIOPHARMACEUTICAL EXECUTIVE, TO ITS BOARD OF DIRECTORS. MS. MCGEE BRINGS EXPERIENCE FROM A BROAD RANGE OF LEADERSHIP ROLES ACROSS OPERATIONS, STRATEGIC PLANNING, MANUFACTURING AND SUPPLY CHAIN MANAGEMENT, QUALITY AND REGULATORY AFFAIRS AND NEW PRODUCT DEVELOPMENT.
|
ZOSANO APPOINTS INDUSTRY VETERAN, KATHY MCGEE, TO ITS BOARD OF DIRECTORS
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-05-12 16:05:00
| null |
FREMONT, CALIF., MAY 12, 2021 (GLOBE NEWSWIRE) -- ZOSANO PHARMA CORPORATION (NASDAQ:ZSAN), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY, TODAY ANNOUNCED FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2021, AS WELL AS BUSINESS HIGHLIGHTS.
|
ZOSANO PHARMA REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-02-22 08:30:00
| null |
FREMONT, CALIF., FEB. 22, 2021 (GLOBE NEWSWIRE) -- ZOSANO PHARMA CORPORATION (NASDAQ:ZSAN), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY, TODAY ANNOUNCED THAT THE COMPANY HAS RECEIVED THE OFFICIAL TYPE A MEETING MINUTES FROM THE U.S. FOOD AND DRUG ADMINISTRATION (“FDA") DIVISION OF NEUROLOGY II (THE “DIVISION”) REGARDING THE REQUIREMENTS FOR RESUBMISSION OF THE QTRYPTA™ (ZOLMITRIPTAN TRANSDERMAL MICRONEEDLE SYSTEM) 505(B)(2) NEW DRUG APPLICATION (“NDA”) FOLLOWING THE COMPLETE RESPONSE LETTER RECEIVED ON OCTOBER 20, 2020.
|
ZOSANO PHARMA CONFIRMS NDA RESUBMISSION STRATEGY FOLLOWING TYPE A MEETING MINUTES FROM FDA
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-02-01 08:30:00
| null |
FREMONT, CALIF., FEB. 01, 2021 (GLOBE NEWSWIRE) -- ZOSANO PHARMA CORPORATION (NASDAQ:ZSAN), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY, TODAY ANNOUNCED THAT EARLY ONSET OF ACTION DATA FOR QTRYPTA™, ZOSANO'S INVESTIGATIONAL THERAPY FOR THE ACUTE TREATMENT OF MIGRAINE FORMULATED UTILIZING ITS MICRONEEDLE SYSTEM, WERE PRESENTED AT THE ANNUAL HEADACHE COOPERATIVE OF THE PACIFIC WINTER CONFERENCE.
|
ZOSANO PHARMA PRESENTS EARLY-ONSET OF ACTION DATA FOR QTRYPTA™ IN ACUTE TREATMENT OF MIGRAINES
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-01-04 16:05:00
| null |
FREMONT, CALIF., JAN. 04, 2021 (GLOBE NEWSWIRE) -- ZOSANO PHARMA CORPORATION (NASDAQ:ZSAN), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY, TODAY ANNOUNCED THAT ON DECEMBER 30, 2020 THE COMPANY REQUESTED A TYPE A MEETING WITH THE U.S. FOOD AND DRUG ADMINISTRATION (FDA).
|
ZOSANO PHARMA REQUESTS TYPE A MEETING WITH THE FDA TO REVIEW RESUBMISSION PLANS FOR QTRYPTA™ NEW DRUG APPLICATION
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-28 11:59:00
| null |
LOS ANGELES--(BUSINESS WIRE)---- $ZSAN #ZSAN--DEADLINE TODAY: THE SCHALL LAW FIRM ANNOUNCES IT IS INVESTIGATING CLAIMS AGAINST ZOSANO PHARMA CORPORATION.
|
DEADLINE TODAY: THE SCHALL LAW FIRM ANNOUNCES IT IS INVESTIGATING CLAIMS AGAINST ZOSANO PHARMA CORPORATION AND ENCOURAGES INVESTORS WITH LOSSES TO CONTACT THE FIRM
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-28 10:00:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 28, 2020) - BRONSTEIN, GEWIRTZ & GROSSMAN, LLC NOTIFIES INVESTORS THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST ZOSANO PHARMA CORPORATION ("ZOSANO" OR THE "COMPANY") (NASDAQ: ZSAN) AND CERTAIN OF ITS OFFICERS, ON BEHALF OF SHAREHOLDERS WHO PURCHASED OR OTHERWISE ACQUIRED ZOSANO SECURITIES BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020, INCLUSIVE (THE "CLASS PERIOD"). SUCH INVESTORS ARE ENCOURAGED TO JOIN THIS CASE BY VISITING THE FIRM'S...
|
ZSAN DEADLINE: BRONSTEIN, GEWIRTZ & GROSSMAN, LLC REMINDS ZOSANO PHARMA CORPORATION OF CLASS ACTION AND ENCOURAGES SHAREHOLDERS TO CONTACT THE FIRM
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-28 09:28:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 28, 2020) - ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF ZOSANO PHARMA CORPORATION (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020, INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT DECEMBER 28, 2020 LEAD PLAINTIFF DEADLINE IN THE SECURITIES CLASS ACTION. THE LAWSUIT SEEKS TO RECOVER DAMAGES FOR ZOSANO INVESTORS UNDER THE FEDERAL SECURITIES LAWS.TO JOIN THE ZOSANO CLASS ACTION,...
|
ZSAN FINAL DEADLINE TODAY: ROSEN, TOP RANKED INVESTOR COUNSEL, REMINDS ZOSANO PHARMA CORPORATION INVESTORS OF IMPORTANT DECEMBER 28 DEADLINE IN SECURITIES CLASS ACTION - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-27 11:00:00
| null |
NEW YORK--(BUSINESS WIRE)--BRONSTEIN, GEWIRTZ & GROSSMAN, LLC NOTIFIES INVESTORS THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST ZOSANO PHARMA CORPORATION ("ZOSANO" OR THE "COMPANY") (NASDAQ: ZSAN) AND CERTAIN OF ITS OFFICERS, ON BEHALF OF SHAREHOLDERS WHO PURCHASED OR OTHERWISE ACQUIRED ZOSANO SECURITIES BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020, INCLUSIVE (THE "CLASS PERIOD"). SUCH INVESTORS ARE ENCOURAGED TO JOIN THIS CASE BY VISITING THE FIRM'S SITE: WWW.BGANDG.COM/ZSAN. THIS
|
ZSAN DEADLINE: BRONSTEIN, GEWIRTZ & GROSSMAN, LLC REMINDS ZOSANO PHARMA CORPORATION OF CLASS ACTION AND ENCOURAGES SHAREHOLDERS TO CONTACT THE FIRM
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-26 15:09:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 26, 2020) - POMERANTZ LLP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST ZOSANO PHARMA CORPORATION ("ZOSANO" OR THE "COMPANY") (NASDAQ: ZSAN) AND CERTAIN OF ITS OFFICERS. THE CLASS ACTION, FILED IN UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA, AND DOCKETED UNDER 20-CV-07850, IS ON BEHALF OF A CLASS CONSISTING OF ALL PERSONS OTHER THAN DEFENDANTS WHO PURCHASED OR OTHERWISE...
|
SHAREHOLDER ALERT: POMERANTZ LAW FIRM REMINDS SHAREHOLDERS WITH LOSSES ON THEIR INVESTMENT IN ZOSANO PHARMA CORPORATION OF CLASS ACTION LAWSUIT AND UPCOMING DEADLINE - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-25 21:00:00
| null |
NEW YORK, DEC. 25, 2020 (GLOBE NEWSWIRE) -- BRAGAR EAGEL & SQUIRE, P.C., A NATIONALLY RECOGNIZED SHAREHOLDER RIGHTS LAW FIRM, REMINDS INVESTORS THAT A CLASS ACTION LAWSUIT HAS BEEN FILED IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA ON BEHALF OF INVESTORS THAT PURCHASED ZOSANO PHARMA CORP. (NASDAQ: ZSAN) SECURITIES BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020 (THE “CLASS PERIOD”). INVESTORS HAVE UNTIL DECEMBER 28, 2020 TO APPLY TO THE COURT TO BE APPOINTED AS LEAD PLAINTIFF IN THE LAWSUIT.
|
DEADLINE ALERT: BRAGAR EAGEL & SQUIRE, P.C. REMINDS INVESTORS THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST ZOSANO PHARMA CORP. AND ENCOURAGES INVESTORS TO CONTACT THE FIRM
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-24 21:07:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 24, 2020) - THE FOLLOWING STATEMENT IS BEING ISSUED BY LEVI & KORSINSKY, LLP:TO: ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED SECURITIES OF ZOSANO PHARMA CORPORATION ("ZOSANO") (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020. YOU ARE HEREBY NOTIFIED THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN COMMENCED IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA. TO GET MORE INFORMATION...
|
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP NOTIFIES SHAREHOLDERS OF ZOSANO PHARMA CORPORATION OF A CLASS ACTION LAWSUIT AND A LEAD PLAINTIFF DEADLINE OF DECEMBER 28, 2020 - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-24 17:18:00
| null |
NEW YORK, DEC. 24, 2020 /PRNEWSWIRE/ -- ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF ZOSANO PHARMA CORPORATION (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020, INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT DECEMBER 28, 2020...
|
ZSAN FINAL DEADLINE MONDAY: ROSEN, A LEADING LAW FIRM, REMINDS ZOSANO PHARMA CORPORATION INVESTORS OF IMPORTANT DECEMBER 28 DEADLINE IN SECURITIES CLASS ACTION - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-24 06:20:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 24, 2020) - THE KLEIN LAW FIRM ANNOUNCES THAT A CLASS ACTION COMPLAINT HAS BEEN FILED ON BEHALF OF SHAREHOLDERS OF ZOSANO PHARMA CORPORATION (NASDAQ: ZSAN) ALLEGING THAT THE COMPANY VIOLATED FEDERAL SECURITIES LAWS.CLASS PERIOD: FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020LEAD PLAINTIFF DEADLINE: DECEMBER 28, 2020LEARN MORE ABOUT YOUR RECOVERABLE LOSSES IN ZSAN:
|
ZSAN ALERT: THE KLEIN LAW FIRM ANNOUNCES A LEAD PLAINTIFF DEADLINE OF DECEMBER 28, 2020 IN THE CLASS ACTION FILED ON BEHALF OF ZOSANO PHARMA CORPORATION LIMITED SHAREHOLDERS
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-23 16:32:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 23, 2020) - THE FOLLOWING STATEMENT IS BEING ISSUED BY LEVI & KORSINSKY, LLP:TO: ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED SECURITIES OF ZOSANO PHARMA CORPORATION ("ZOSANO") (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020. YOU ARE HEREBY NOTIFIED THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN COMMENCED IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA. TO GET MORE INFORMATION...
|
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP NOTIFIES SHAREHOLDERS OF ZOSANO PHARMA CORPORATION OF A CLASS ACTION LAWSUIT AND A LEAD PLAINTIFF DEADLINE OF DECEMBER 28, 2020 - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-23 14:08:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 23, 2020) - ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF ZOSANO PHARMA CORPORATION (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020, INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT DECEMBER 28, 2020 LEAD PLAINTIFF DEADLINE IN THE SECURITIES CLASS ACTION. THE LAWSUIT SEEKS TO RECOVER DAMAGES FOR ZOSANO INVESTORS UNDER THE FEDERAL SECURITIES LAWS.TO JOIN THE ZOSANO CLASS...
|
ZSAN FINAL DEADLINE ALERT: ROSEN, RESPECTED INVESTOR COUNSEL, REMINDS ZOSANO PHARMA CORPORATION INVESTORS OF IMPORTANT MONDAY DEADLINE IN SECURITIES CLASS ACTION - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-22 14:15:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 22, 2020) - THE FOLLOWING STATEMENT IS BEING ISSUED BY LEVI & KORSINSKY, LLP:TO: ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED SECURITIES OF ZOSANO PHARMA CORPORATION ("ZOSANO") (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020. YOU ARE HEREBY NOTIFIED THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN COMMENCED IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA. TO GET MORE...
|
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP NOTIFIES SHAREHOLDERS OF ZOSANO PHARMA CORPORATION OF A CLASS ACTION LAWSUIT AND A LEAD PLAINTIFF DEADLINE OF DECEMBER 28, 2020 - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-22 09:00:00
| null |
INVESTORS WITH LOSSES ARE ENCOURAGED TO CONTACT THE FIRM BEFORE DECEMBER 28, 2020 ; CLICK HERE TO SUBMIT TRADE INFORMATION
|
ZOSANO PHARMA CORPORATION: LAST DAYS TO PARTICIPATE ACTIVELY IN THE CLASS ACTION LAWSUIT: PORTNOY LAW FIRM
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-21 21:00:00
| null |
NEW YORK--(BUSINESS WIRE)-- #CLASSACTION--BRAGAR EAGEL & SQUIRE, P.C., A NATIONALLY RECOGNIZED SHAREHOLDER RIGHTS LAW FIRM, REMINDS INVESTORS THAT A CLASS ACTION LAWSUIT HAS BEEN FILED IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA ON BEHALF OF INVESTORS THAT PURCHASED ZOSANO PHARMA CORP. (NASDAQ: ZSAN) SECURITIES BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020 (THE “CLASS PERIOD”). INVESTORS HAVE UNTIL DECEMBER 28, 2020 TO APPLY TO THE COURT TO BE APPOINTED AS LEAD PLAINTIFF
|
ZOSANO ALERT: BRAGAR EAGEL & SQUIRE, P.C. REMINDS INVESTORS THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST ZOSANO PHARMA CORP. AND ENCOURAGES INVESTORS TO CONTACT THE FIRM
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-21 13:42:00
| null |
NEW YORK, DEC. 21, 2020 (GLOBE NEWSWIRE) -- PAWAR LAW GROUP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED ON BEHALF OF SHAREHOLDERS WHO PURCHASED SHARES OF ZOSANO PHARMA CORPORATION (NASDAQ: ZSAN) FROM FEBRUARY 13, 2017 THROUGH SEPTEMBER 30, 2020, INCLUSIVE (THE “CLASS PERIOD”). THE LAWSUIT SEEKS TO RECOVER DAMAGES FOR ZOSANO PHARMA CORPORATION INVESTORS UNDER THE FEDERAL SECURITIES LAWS.
|
DEC. 28 INVESTOR DEADLINE-ZSAN: PAWAR LAW GROUP ANNOUNCES A SECURITIES CLASS ACTION LAWSUIT AGAINST ZOSANO PHARMA CORPORATION – ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-21 06:14:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 21, 2020) - THE FOLLOWING STATEMENT IS BEING ISSUED BY LEVI & KORSINSKY, LLP:TO: ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED SECURITIES OF ZOSANO PHARMA CORPORATION ("ZOSANO") (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020. YOU ARE HEREBY NOTIFIED THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN COMMENCED IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA. TO GET MORE INFORMATION...
|
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP NOTIFIES SHAREHOLDERS OF ZOSANO PHARMA CORPORATION OF A CLASS ACTION LAWSUIT AND A LEAD PLAINTIFF DEADLINE OF DECEMBER 28, 2020 - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-19 17:19:00
| null |
NEW YORK, DEC. 19, 2020 (GLOBE NEWSWIRE) -- POMERANTZ LLP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST ZOSANO PHARMA CORPORATION (“ZOSANO” OR THE “COMPANY”) (NASDAQ: ZSAN) AND CERTAIN OF ITS OFFICERS. THE CLASS ACTION, FILED IN UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA, AND DOCKETED UNDER 20-CV-07850, IS ON BEHALF OF A CLASS CONSISTING OF ALL PERSONS OTHER THAN DEFENDANTS WHO PURCHASED OR OTHERWISE ACQUIRED ZOSANO SECURITIES BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020, INCLUSIVE (THE “CLASS PERIOD”), SEEKING TO PURSUE CLAIMS AGAINST THE DEFENDANTS UNDER THE SECURITIES EXCHANGE ACT OF 1934 (THE “EXCHANGE ACT”).
|
SHAREHOLDER ALERT: POMERANTZ LAW FIRM REMINDS SHAREHOLDERS WITH LOSSES ON THEIR INVESTMENT IN ZOSANO PHARMA CORPORATION OF CLASS ACTION LAWSUIT AND UPCOMING DEADLINE – ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-17 18:51:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 17, 2020) - THE FOLLOWING STATEMENT IS BEING ISSUED BY LEVI & KORSINSKY, LLP:TO: ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED SECURITIES OF ZOSANO PHARMA CORPORATION ("ZOSANO") (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020. YOU ARE HEREBY NOTIFIED THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN COMMENCED IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA. TO GET MORE INFORMATION...
|
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP NOTIFIES SHAREHOLDERS OF ZOSANO PHARMA CORPORATION OF A CLASS ACTION LAWSUIT AND A LEAD PLAINTIFF DEADLINE OF DECEMBER 28, 2020 - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-17 17:19:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 17, 2020) - ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF ZOSANO PHARMA CORPORATION (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020, INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT DECEMBER 28, 2020 LEAD PLAINTIFF DEADLINE IN THE SECURITIES CLASS ACTION. THE LAWSUIT SEEKS TO RECOVER DAMAGES FOR ZOSANO INVESTORS UNDER THE FEDERAL SECURITIES LAWS.TO JOIN THE ZOSANO CLASS ACTION,...
|
ROSEN, A LEADING LAW FIRM, REMINDS ZOSANO PHARMA CORPORATION INVESTORS OF IMPORTANT DECEMBER 28 DEADLINE IN SECURITIES CLASS ACTION - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-17 14:02:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 17, 2020) - THE KLEIN LAW FIRM ANNOUNCES THAT A CLASS ACTION COMPLAINT HAS BEEN FILED ON BEHALF OF SHAREHOLDERS OF ZOSANO PHARMA CORPORATION (NASDAQ: ZSAN) ALLEGING THAT THE COMPANY VIOLATED FEDERAL SECURITIES LAWS.CLASS PERIOD: FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020LEAD PLAINTIFF DEADLINE: DECEMBER 28, 2020LEARN MORE ABOUT YOUR RECOVERABLE LOSSES IN ZSAN:
|
ZSAN ALERT: THE KLEIN LAW FIRM ANNOUNCES A LEAD PLAINTIFF DEADLINE OF DECEMBER 28, 2020 IN THE CLASS ACTION FILED ON BEHALF OF ZOSANO PHARMA CORPORATION LIMITED SHAREHOLDERS
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-17 11:30:00
| null |
LOS ANGELES, DEC. 17, 2020 (GLOBE NEWSWIRE) -- GLANCY PRONGAY & MURRAY LLP (“GPM”) REMINDS INVESTORS OF THE UPCOMING DECEMBER 28, 2020 DEADLINE TO FILE A LEAD PLAINTIFF MOTION IN THE CLASS ACTION FILED ON BEHALF OF INVESTORS WHO PURCHASED OR OTHERWISE ACQUIRED ZOSANO PHARMA CORPORATION (“ZOSANO” OR THE “COMPANY”) (NASDAQ: ZSAN ) SECURITIES BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020, INCLUSIVE (THE “CLASS PERIOD”).
|
GLANCY PRONGAY & MURRAY LLP REMINDS INVESTORS OF LOOMING DEADLINE IN THE CLASS ACTION LAWSUIT AGAINST ZOSANO PHARMA CORPORATION (ZSAN)
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-16 15:42:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 16, 2020) - THE FOLLOWING STATEMENT IS BEING ISSUED BY LEVI & KORSINSKY, LLP:TO: ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED SECURITIES OF ZOSANO PHARMA CORPORATION ("ZOSANO") (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020. YOU ARE HEREBY NOTIFIED THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN COMMENCED IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA. TO GET MORE INFORMATION...
|
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP NOTIFIES SHAREHOLDERS OF ZOSANO PHARMA CORPORATION OF A CLASS ACTION LAWSUIT AND A LEAD PLAINTIFF DEADLINE OF DECEMBER 28, 2020 - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-15 14:27:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 15, 2020) - THE FOLLOWING STATEMENT IS BEING ISSUED BY LEVI & KORSINSKY, LLP:TO: ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED SECURITIES OF ZOSANO PHARMA CORPORATION ("ZOSANO") (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020. YOU ARE HEREBY NOTIFIED THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN COMMENCED IN THE THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA. TO GET MORE...
|
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP NOTIFIES SHAREHOLDERS OF ZOSANO PHARMA CORPORATION OF A CLASS ACTION LAWSUIT AND A LEAD PLAINTIFF DEADLINE OF DECEMBER 28, 2020 - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-15 12:24:00
| null |
NEW YORK, DEC. 15, 2020 (GLOBE NEWSWIRE) -- PAWAR LAW GROUP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED ON BEHALF OF SHAREHOLDERS WHO PURCHASED SHARES OF ZOSANO PHARMA CORPORATION (NASDAQ: ZSAN) FROM FEBRUARY 13, 2017 THROUGH SEPTEMBER 30, 2020, INCLUSIVE (THE “CLASS PERIOD”). THE LAWSUIT SEEKS TO RECOVER DAMAGES FOR ZOSANO PHARMA CORPORATION INVESTORS UNDER THE FEDERAL SECURITIES LAWS.
|
IMPORTANT DEC. 28 DEADLINE-ZSAN: PAWAR LAW GROUP ANNOUNCES A SECURITIES CLASS ACTION LAWSUIT AGAINST ZOSANO PHARMA CORPORATION– ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-14 21:06:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 14, 2020) - POMERANTZ LLP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST ZOSANO PHARMA CORPORATION ("ZOSANO" OR THE "COMPANY") (NASDAQ: ZSAN) AND CERTAIN OF ITS OFFICERS. THE CLASS ACTION, FILED IN UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA, AND DOCKETED UNDER 20-CV-07850, IS ON BEHALF OF A CLASS CONSISTING OF ALL PERSONS OTHER THAN DEFENDANTS WHO PURCHASED OR OTHERWISE ACQUIRED...
|
SHAREHOLDER ALERT: POMERANTZ LAW FIRM REMINDS SHAREHOLDERS WITH LOSSES ON THEIR INVESTMENT IN ZOSANO PHARMA CORPORATION OF CLASS ACTION LAWSUIT AND UPCOMING DEADLINE - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-14 13:00:00
| null |
LOS ANGELES, DEC. 14, 2020 /PRNEWSWIRE/ -- GLANCY PRONGAY & MURRAY LLP ("GPM") REMINDS INVESTORS OF THE UPCOMING DECEMBER 28, 2020 DEADLINE TO FILE A LEAD PLAINTIFF MOTION IN THE CLASS ACTION FILED ON BEHALF OF INVESTORS WHO PURCHASED OR OTHERWISE ACQUIRED ZOSANO PHARMA CORPORATION...
|
GLANCY PRONGAY & MURRAY LLP REMINDS INVESTORS OF LOOMING DEADLINE IN THE CLASS ACTION LAWSUIT AGAINST ZOSANO PHARMA CORPORATION (ZSAN)
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-13 00:04:00
| null |
NEW YORK, DEC. 13, 2020 (GLOBE NEWSWIRE) -- POMERANTZ LLP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST ZOSANO PHARMA CORPORATION (“ZOSANO” OR THE “COMPANY”) (NASDAQ: ZSAN) AND CERTAIN OF ITS OFFICERS. THE CLASS ACTION, FILED IN UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA, AND DOCKETED UNDER 20-CV-07850, IS ON BEHALF OF A CLASS CONSISTING OF ALL PERSONS OTHER THAN DEFENDANTS WHO PURCHASED OR OTHERWISE ACQUIRED ZOSANO SECURITIES BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020, INCLUSIVE (THE “CLASS PERIOD”), SEEKING TO PURSUE CLAIMS AGAINST THE DEFENDANTS UNDER THE SECURITIES EXCHANGE ACT OF 1934 (THE “EXCHANGE ACT”).
|
SHAREHOLDER ALERT: POMERANTZ LAW FIRM REMINDS SHAREHOLDERS WITH LOSSES ON THEIR INVESTMENT IN ZOSANO PHARMA CORPORATION OF CLASS ACTION LAWSUIT AND UPCOMING DEADLINE – ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-12 09:00:00
| null |
NEW YORK, DEC. 12, 2020 (GLOBE NEWSWIRE) -- ZHANG INVESTOR LAW ANNOUNCES A CLASS ACTION LAWSUIT ON BEHALF OF SHAREHOLDERS WHO BOUGHT SHARES OF ZOSANO PHARMA CORPORATION (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020, INCLUSIVE (THE “CLASS PERIOD”).
|
LOOMING DEADLINE ZHANG INVESTOR LAW REMINDS INVESTORS OF DEADLINE IN SECURITIES CLASS ACTION LAWSUIT AGAINST ZOSANO PHARMA CORPORATION – ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-10 20:56:00
| null |
NEW YORK, DEC. 10, 2020 /PRNEWSWIRE/ -- ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF ZOSANO PHARMA CORPORATION (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020, INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT DECEMBER 28, 2020...
|
ROSEN, A LEADING LAW FIRM, REMINDS ZOSANO PHARMA CORPORATION INVESTORS OF IMPORTANT DECEMBER 28 DEADLINE IN SECURITIES CLASS ACTION; ENCOURAGES INVESTORS WITH LOSSES IN EXCESS OF $100K TO CONTACT FIRM - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-10 06:14:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 10, 2020) - THE KLEIN LAW FIRM ANNOUNCES THAT A CLASS ACTION COMPLAINT HAS BEEN FILED ON BEHALF OF SHAREHOLDERS OF ZOSANO PHARMA CORPORATION (NASDAQ: ZSAN) ALLEGING THAT THE COMPANY VIOLATED FEDERAL SECURITIES LAWS.CLASS PERIOD: FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020LEAD PLAINTIFF DEADLINE: DECEMBER 28, 2020LEARN MORE ABOUT YOUR RECOVERABLE LOSSES IN ZSAN:
|
ZSAN ALERT: THE KLEIN LAW FIRM ANNOUNCES A LEAD PLAINTIFF DEADLINE OF DECEMBER 28, 2020 IN THE CLASS ACTION FILED ON BEHALF OF ZOSANO PHARMA CORPORATION LIMITED SHAREHOLDERS
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-09 09:31:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 9, 2020) - THE FOLLOWING STATEMENT IS BEING ISSUED BY LEVI & KORSINSKY, LLP:TO: ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED SECURITIES OF ZOSANO PHARMA CORPORATION (NASDAQ: ZSAN) ("ZOSANO") BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020. YOU ARE HEREBY NOTIFIED THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN COMMENCED IN THE THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA. TO GET...
|
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP NOTIFIES SHAREHOLDERS OF ZOSANO PHARMA CORPORATION OF A CLASS ACTION LAWSUIT AND A LEAD PLAINTIFF DEADLINE OF DECEMBER 28, 2020 - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-08 12:27:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 8, 2020) - THE KLEIN LAW FIRM ANNOUNCES THAT A CLASS ACTION COMPLAINT HAS BEEN FILED ON BEHALF OF SHAREHOLDERS OF ZOSANO PHARMA CORPORATION (NASDAQ: ZSAN) ALLEGING THAT THE COMPANY VIOLATED FEDERAL SECURITIES LAWS.CLASS PERIOD: FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020LEAD PLAINTIFF DEADLINE: DECEMBER 28, 2020LEARN MORE ABOUT YOUR RECOVERABLE LOSSES IN ZSAN:
|
ZSAN ALERT: THE KLEIN LAW FIRM ANNOUNCES A LEAD PLAINTIFF DEADLINE OF DECEMBER 28, 2020 IN THE CLASS ACTION FILED ON BEHALF OF ZOSANO PHARMA CORPORATION LIMITED SHAREHOLDERS
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-08 12:11:00
| null |
NEW YORK, DEC. 08, 2020 (GLOBE NEWSWIRE) -- PAWAR LAW GROUP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED ON BEHALF OF SHAREHOLDERS WHO PURCHASED SHARES OF ZOSANO PHARMA CORPORATION (NASDAQ: ZSAN) FROM FEBRUARY 13, 2017 THROUGH SEPTEMBER 30, 2020, INCLUSIVE (THE “CLASS PERIOD”). THE LAWSUIT SEEKS TO RECOVER DAMAGES FOR ZOSANO PHARMA CORPORATION INVESTORS UNDER THE FEDERAL SECURITIES LAWS.
|
LOOMING ZSAN DEADLINE: PAWAR LAW GROUP ANNOUNCES A SECURITIES CLASS ACTION LAWSUIT AGAINST ZOSANO PHARMA CORPORATION – ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-07 21:22:00
| null |
NEW YORK, DEC. 07, 2020 (GLOBE NEWSWIRE) -- POMERANTZ LLP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST ZOSANO PHARMA CORPORATION (“ZOSANO” OR THE “COMPANY”) (NASDAQ: ZSAN) AND CERTAIN OF ITS OFFICERS. THE CLASS ACTION, FILED IN UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA, AND DOCKETED UNDER 20-CV-07850, IS ON BEHALF OF A CLASS CONSISTING OF ALL PERSONS OTHER THAN DEFENDANTS WHO PURCHASED OR OTHERWISE ACQUIRED ZOSANO SECURITIES BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020, INCLUSIVE (THE “CLASS PERIOD”), SEEKING TO PURSUE CLAIMS AGAINST THE DEFENDANTS UNDER THE SECURITIES EXCHANGE ACT OF 1934 (THE “EXCHANGE ACT”).
|
SHAREHOLDER ALERT: POMERANTZ LAW FIRM REMINDS SHAREHOLDERS WITH LOSSES ON THEIR INVESTMENT IN ZOSANO PHARMA CORPORATION OF CLASS ACTION LAWSUIT AND UPCOMING DEADLINE – ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-07 19:22:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 7, 2020) - THE FOLLOWING STATEMENT IS BEING ISSUED BY LEVI & KORSINSKY, LLP:TO: ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED SECURITIES OF ZOSANO PHARMA CORPORATION ("ZOSANO") (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020. YOU ARE HEREBY NOTIFIED THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN COMMENCED IN THE THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA. TO GET MORE...
|
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP NOTIFIES SHAREHOLDERS OF ZOSANO PHARMA CORPORATION OF A CLASS ACTION LAWSUIT AND A LEAD PLAINTIFF DEADLINE OF DECEMBER 28, 2020 - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-07 17:52:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 7, 2020) - ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF ZOSANO PHARMA CORPORATION (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020, INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT DECEMBER 28, 2020 LEAD PLAINTIFF DEADLINE IN THE SECURITIES CLASS ACTION. THE LAWSUIT SEEKS TO RECOVER DAMAGES FOR ZOSANO INVESTORS UNDER THE FEDERAL SECURITIES LAWS.TO JOIN THE ZOSANO CLASS...
|
ROSEN, GLOBAL INVESTOR COUNSEL, REMINDS ZOSANO PHARMA CORPORATION INVESTORS OF IMPORTANT DECEMBER 28 DEADLINE IN SECURITIES CLASS ACTION; ENCOURAGES INVESTORS WITH LOSSES IN EXCESS OF $100K TO CONTACT FIRM - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-04 19:28:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 4, 2020) - THE FOLLOWING STATEMENT IS BEING ISSUED BY LEVI & KORSINSKY, LLP:TO: ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED SECURITIES OF ZOSANO PHARMA CORPORATION ("ZOSANO") (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020. YOU ARE HEREBY NOTIFIED THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN COMMENCED IN THE THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA. TO GET MORE...
|
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP NOTIFIES SHAREHOLDERS OF ZOSANO PHARMA CORPORATION OF A CLASS ACTION LAWSUIT AND A LEAD PLAINTIFF DEADLINE OF DECEMBER 28, 2020 - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-03 20:30:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 3, 2020) - ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF ZOSANO PHARMA CORPORATION (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020, INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT DECEMBER 28, 2020 LEAD PLAINTIFF DEADLINE IN THE SECURITIES CLASS ACTION. THE LAWSUIT SEEKS TO RECOVER DAMAGES FOR ZOSANO INVESTORS UNDER THE FEDERAL SECURITIES LAWS.TO JOIN THE ZOSANO CLASS ACTION,...
|
ROSEN, A GLOBAL AND LEADING LAW FIRM, REMINDS ZOSANO PHARMA CORPORATION INVESTORS OF IMPORTANT DEADLINE IN SECURITIES CLASS ACTION; ENCOURAGES INVESTORS WITH LOSSES IN EXCESS OF $100K TO CONTACT FIRM - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-03 04:40:00
| null |
NEW YORK, DEC. 3, 2020 /PRNEWSWIRE/ -- POMERANTZ LLP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST ZOSANO PHARMA CORPORATION ("ZOSANO" OR THE "COMPANY") (NASDAQ: ZSAN) AND CERTAIN OF ITS OFFICERS. THE CLASS ACTION, FILED IN UNITED STATES DISTRICT COURT FOR THE NORTHERN...
|
SHAREHOLDER ALERT: POMERANTZ LAW FIRM REMINDS SHAREHOLDERS WITH LOSSES ON THEIR INVESTMENT IN ZOSANO PHARMA CORPORATION OF CLASS ACTION LAWSUIT AND UPCOMING DEADLINE - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-26 21:27:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 26, 2020) - THE FOLLOWING STATEMENT IS BEING ISSUED BY LEVI & KORSINSKY, LLP:TO: ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED SECURITIES OF ZOSANO PHARMA CORPORATION ("ZOSANO") (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020. YOU ARE HEREBY NOTIFIED THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN COMMENCED IN THE THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA. TO GET MORE...
|
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP NOTIFIES SHAREHOLDERS OF ZOSANO PHARMA CORPORATION OF A CLASS ACTION LAWSUIT AND A LEAD PLAINTIFF DEADLINE OF DECEMBER 28, 2020 - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-25 23:27:00
| null |
NEW YORK, NOV. 25, 2020 (GLOBE NEWSWIRE) -- POMERANTZ LLP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST ZOSANO PHARMA CORPORATION (“ZOSANO” OR THE “COMPANY”) (NASDAQ: ZSAN) AND CERTAIN OF ITS OFFICERS. THE CLASS ACTION, FILED IN UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA, AND DOCKETED UNDER 20-CV-07850, IS ON BEHALF OF A CLASS CONSISTING OF ALL PERSONS OTHER THAN DEFENDANTS WHO PURCHASED OR OTHERWISE ACQUIRED ZOSANO SECURITIES BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020, INCLUSIVE (THE “CLASS PERIOD”), SEEKING TO PURSUE CLAIMS AGAINST THE DEFENDANTS UNDER THE SECURITIES EXCHANGE ACT OF 1934 (THE “EXCHANGE ACT”).
|
SHAREHOLDER ALERT: POMERANTZ LAW FIRM REMINDS SHAREHOLDERS WITH LOSSES ON THEIR INVESTMENT IN ZOSANO PHARMA CORPORATION OF CLASS ACTION LAWSUIT AND UPCOMING DEADLINE – ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-24 22:28:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 24, 2020) - THE FOLLOWING STATEMENT IS BEING ISSUED BY LEVI & KORSINSKY, LLP:TO: ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED SECURITIES OF ZOSANO PHARMA CORPORATION ("ZOSANO") (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020. YOU ARE HEREBY NOTIFIED THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN COMMENCED IN THE THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA. TO GET MORE...
|
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP NOTIFIES SHAREHOLDERS OF ZOSANO PHARMA CORPORATION OF A CLASS ACTION LAWSUIT AND A LEAD PLAINTIFF DEADLINE OF DECEMBER 28, 2020 - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-21 17:00:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 21, 2020) - ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF ZOSANO PHARMA CORPORATION (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020, INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT DECEMBER 28, 2020 LEAD PLAINTIFF DEADLINE IN THE SECURITIES CLASS ACTION. THE LAWSUIT SEEKS TO RECOVER DAMAGES FOR ZOSANO INVESTORS UNDER THE FEDERAL SECURITIES LAWS.TO JOIN THE ZOSANO CLASS ACTION,...
|
ROSEN, A TOP RANKED LAW FIRM, REMINDS ZOSANO PHARMA CORPORATION INVESTORS OF IMPORTANT DEADLINE IN SECURITIES CLASS ACTION; ENCOURAGES INVESTORS WITH LOSSES IN EXCESS OF $100K TO CONTACT FIRM - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-16 18:30:00
| null |
FREMONT, CALIF., NOV. 16, 2020 (GLOBE NEWSWIRE) -- ZOSANO PHARMA CORPORATION (NASDAQ:ZSAN), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY, TODAY ANNOUNCED THAT THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS GRANTED A STOCK OPTION TO PURCHASE 100,000 SHARES OF ZOSANO'S COMMON STOCK TO A NEW EMPLOYEE AS AN INDUCEMENT AWARD.
|
ZOSANO PHARMA ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-16 17:19:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 16, 2020) - THE FOLLOWING STATEMENT IS BEING ISSUED BY LEVI & KORSINSKY, LLP:TO: ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED SECURITIES OF ZOSANO PHARMA CORPORATION ("ZOSANO") (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020. YOU ARE HEREBY NOTIFIED THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN COMMENCED IN THE THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA. TO GET MORE...
|
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP NOTIFIES SHAREHOLDERS OF ZOSANO PHARMA CORPORATION OF A CLASS ACTION LAWSUIT AND A LEAD PLAINTIFF DEADLINE OF DECEMBER 28, 2020 - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-16 11:00:00
| null |
LOS ANGELES, NOV. 16, 2020 /PRNEWSWIRE/ -- GLANCY PRONGAY & MURRAY LLP ("GPM") REMINDS INVESTORS OF THE UPCOMING DECEMBER 28, 2020 DEADLINE TO FILE A LEAD PLAINTIFF MOTION IN THE CLASS ACTION FILED ON BEHALF OF INVESTORS WHO PURCHASED OR OTHERWISE ACQUIRED ZOSANO PHARMA CORPORATION...
|
GLANCY PRONGAY & MURRAY LLP REMINDS INVESTORS OF LOOMING DEADLINE IN THE CLASS ACTION LAWSUIT AGAINST ZOSANO PHARMA CORPORATION (ZSAN)
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-13 17:00:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 13, 2020) - ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF ZOSANO PHARMA CORPORATION (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020, INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT DECEMBER 28, 2020 LEAD PLAINTIFF DEADLINE IN THE SECURITIES CLASS ACTION. THE LAWSUIT SEEKS TO RECOVER DAMAGES FOR ZOSANO INVESTORS UNDER THE FEDERAL SECURITIES LAWS.TO JOIN THE ZOSANO CLASS ACTION,...
|
ROSEN, A LEADING LAW FIRM, REMINDS ZOSANO PHARMA CORPORATION INVESTORS OF IMPORTANT DEADLINE IN SECURITIES CLASS ACTION; ENCOURAGES INVESTORS WITH LOSSES IN EXCESS OF $100K TO CONTACT THE FIRM - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-13 16:05:00
| null |
FREMONT, CALIF., NOV. 13, 2020 (GLOBE NEWSWIRE) -- ZOSANO PHARMA CORPORATION (NASDAQ:ZSAN), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY, TODAY ANNOUNCED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2020, AS WELL AS RECENT BUSINESS UPDATES.
|
ZOSANO PHARMA REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-13 12:32:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 13, 2020) - THE FOLLOWING STATEMENT IS BEING ISSUED BY LEVI & KORSINSKY, LLP:TO: ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED SECURITIES OF ZOSANO PHARMA CORPORATION ("ZOSANO") (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020. YOU ARE HEREBY NOTIFIED THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN COMMENCED IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA. TO GET MORE...
|
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP NOTIFIES SHAREHOLDERS OF ZOSANO PHARMA CORPORATION OF A CLASS ACTION LAWSUIT AND A LEAD PLAINTIFF DEADLINE OF DECEMBER 28, 2020 - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-12 10:45:00
| null |
LOS ANGELES, NOV. 12, 2020 /PRNEWSWIRE/ -- THE LAW OFFICES OF FRANK R. CRUZ REMINDS INVESTORS OF THE UPCOMING DECEMBER 28, 2020 DEADLINE TO FILE A LEAD PLAINTIFF MOTION IN THE CLASS ACTION FILED ON BEHALF OF INVESTORS WHO PURCHASED OR OTHERWISE ACQUIRED ZOSANO PHARMA CORPORATION ("ZOSANO"...
|
THE LAW OFFICES OF FRANK R. CRUZ REMINDS INVESTORS OF LOOMING DEADLINE IN THE CLASS ACTION LAWSUIT AGAINST ZOSANO PHARMA CORPORATION (ZSAN)
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-10 17:00:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 10, 2020) - THE BRUALDI LAW FIRM, P.C. ANNOUNCES THAT A LAWSUIT HAS BEEN COMMENCED IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA ON BEHALF OF PURCHASERS OF ZOSANO PHARMA CORPORATION ("ZOSANO" OR THE "COMPANY") (NASDAQ: ZSAN) STOCK DURING THE PERIOD BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020, INCLUSIVE (THE "CLASS PERIOD"), FOR VIOLATIONS OF THE FEDERAL SECURITIES LAWS.NO CLASS HAS YET BEEN...
|
THE BRUALDI LAW FIRM, P.C. ANNOUNCES CLASS ACTION LAWSUIT AGAINST ZOSANO PHARMA CORPORATION
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-10 12:57:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 10, 2020) - THE KLEIN LAW FIRM ANNOUNCES THAT A CLASS ACTION COMPLAINT HAS BEEN FILED ON BEHALF OF SHAREHOLDERS OF ZOSANO PHARMA CORPORATION (NASDAQ: ZSAN) ALLEGING THAT THE COMPANY VIOLATED FEDERAL SECURITIES LAWS.CLASS PERIOD: FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020LEAD PLAINTIFF DEADLINE: DECEMBER 28, 2020LEARN MORE ABOUT YOUR RECOVERABLE LOSSES IN ZSAN:
|
ZSAN ALERT: THE KLEIN LAW FIRM ANNOUNCES A LEAD PLAINTIFF DEADLINE OF DECEMBER 28, 2020 IN THE CLASS ACTION FILED ON BEHALF OF ZOSANO PHARMA CORPORATION LIMITED SHAREHOLDERS
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-10 11:30:00
| null |
BENSALEM, PA., NOV. 10, 2020 /PRNEWSWIRE/ -- LAW OFFICES OF HOWARD G. SMITH REMINDS INVESTORS OF THE UPCOMING DECEMBER 28, 2020 DEADLINE TO FILE A LEAD PLAINTIFF MOTION IN THE CLASS ACTION FILED ON BEHALF OF INVESTORS WHO PURCHASED OR OTHERWISE ACQUIRED ZOSANO PHARMA CORPORATION ("ZOSANO"...
|
DEADLINE REMINDER: LAW OFFICES OF HOWARD G. SMITH REMINDS INVESTORS OF LOOMING DEADLINE IN THE CLASS ACTION LAWSUIT AGAINST ZOSANO PHARMA CORPORATION (ZSAN)
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-09 20:53:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 9, 2020) - THE FOLLOWING STATEMENT IS BEING ISSUED BY LEVI & KORSINSKY, LLP:TO: ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED SECURITIES OF ZOSANO PHARMA CORPORATION ("ZOSANO") (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020. YOU ARE HEREBY NOTIFIED THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN COMMENCED IN THE THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA. TO GET MORE...
|
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP NOTIFIES SHAREHOLDERS OF ZOSANO PHARMA CORPORATION OF A CLASS ACTION LAWSUIT AND A LEAD PLAINTIFF DEADLINE OF DECEMBER 28, 2020 - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-09 19:26:00
| null |
NEW YORK, NOV. 9, 2020 /PRNEWSWIRE/ -- ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF ZOSANO PHARMA CORPORATION (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020, INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT DECEMBER 28, 2020...
|
ROSEN, A LEADING LAW FIRM, REMINDS ZOSANO PHARMA CORPORATION INVESTORS OF IMPORTANT DEADLINE IN SECURITIES CLASS ACTION; ENCOURAGES INVESTORS WITH LOSSES IN EXCESS OF $100K TO CONTACT THE FIRM - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-06 23:54:00
| null |
NEW YORK, NOV. 6, 2020 /PRNEWSWIRE/ -- POMERANTZ LLP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST ZOSANO PHARMA CORPORATION ("ZOSANO" OR THE "COMPANY") (NASDAQ: ZSAN) AND CERTAIN OF ITS OFFICERS. THE CLASS ACTION, FILED IN UNITED STATES DISTRICT COURT FOR THE NORTHERN...
|
POMERANTZ LAW FIRM ANNOUNCES THE FILING OF A CLASS ACTION AGAINST ZOSANO PHARMA CORPORATION AND CERTAIN OFFICERS - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-06 11:30:00
| null |
BENSALEM, PA.--(BUSINESS WIRE)---- $ZSAN--DEADLINE REMINDER: LAW OFFICES OF HOWARD G. SMITH REMINDS INVESTORS OF LOOMING DEADLINE IN THE CLASS ACTION LAWSUIT AGAINST ZOSANO PHARMA CORPORATION
|
DEADLINE REMINDER: LAW OFFICES OF HOWARD G. SMITH REMINDS INVESTORS OF LOOMING DEADLINE IN THE CLASS ACTION LAWSUIT AGAINST ZOSANO PHARMA CORPORATION (ZSAN)
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-04 22:29:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 4, 2020) - THE FOLLOWING STATEMENT IS BEING ISSUED BY LEVI & KORSINSKY, LLP:TO: ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED SECURITIES OF ZOSANO PHARMA CORPORATION ("ZOSANO") (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020. YOU ARE HEREBY NOTIFIED THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN COMMENCED IN THE THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA. TO GET MORE...
|
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP NOTIFIES SHAREHOLDERS OF ZOSANO PHARMA CORPORATION OF A CLASS ACTION LAWSUIT AND A LEAD PLAINTIFF DEADLINE OF DECEMBER 28, 2020 - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-04 17:42:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 4, 2020) - ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, ANNOUNCES THE FILING OF A CLASS ACTION LAWSUIT ON BEHALF OF PURCHASERS OF THE SECURITIES OF ZOSANO PHARMA CORPORATION (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020, INCLUSIVE (THE "CLASS PERIOD"). THE LAWSUIT SEEKS TO RECOVER DAMAGES FOR ZOSANO INVESTORS UNDER THE FEDERAL SECURITIES LAWS.TO JOIN THE ZOSANO CLASS ACTION, GO TO HTTP://WWW.ROSENLEGAL.COM/CASES-REGISTER-1963.HTML OR...
|
ROSEN, GLOBAL INVESTOR COUNSEL, ANNOUNCES FILING OF SECURITIES CLASS ACTION LAWSUIT AGAINST ZOSANO PHARMA CORPORATION; ENCOURAGES INVESTORS WITH LOSSES IN EXCESS OF $100K TO CONTACT THE FIRM - ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-04 12:00:00
| null |
LOS ANGELES--(BUSINESS WIRE)---- $ZSAN #CLASSACTION--GLANCY PRONGAY & MURRAY LLP REMINDS INVESTORS OF LOOMING DEADLINE IN THE CLASS ACTION LAWSUIT AGAINST ZOSANO PHARMA CORPORATION (ZSAN)
|
GLANCY PRONGAY & MURRAY LLP REMINDS INVESTORS OF LOOMING DEADLINE IN THE CLASS ACTION LAWSUIT AGAINST ZOSANO PHARMA CORPORATION (ZSAN)
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-03 11:30:00
| null |
BENSALEM, PA.--(BUSINESS WIRE)---- $ZSAN #CLASSACTION--INVESTOR ALERT: LAW OFFICES OF HOWARD G. SMITH ANNOUNCES FILING OF A SECURITIES CLASS ACTION ON BEHALF OF ZOSANO PHARMA CORPORATION (ZSAN) INVESTORS
|
INVESTOR ALERT: LAW OFFICES OF HOWARD G. SMITH ANNOUNCES THE FILING OF A SECURITIES CLASS ACTION ON BEHALF OF ZOSANO PHARMA CORPORATION (ZSAN) INVESTORS
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-03 11:00:00
| null |
NEW YORK, NOV. 3, 2020 /PRNEWSWIRE/ -- ATTORNEY ADVERTISING -- BRONSTEIN, GEWIRTZ & GROSSMAN, LLC NOTIFIES INVESTORS THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST ZOSANO PHARMA CORPORATION ("ZOSANO" OR THE "COMPANY") (NASDAQ: ZSAN) AND CERTAIN OF ITS OFFICERS, ON BEHALF OF...
|
ZSAN SHAREHOLDER ALERT: BRONSTEIN, GEWIRTZ & GROSSMAN, LLC NOTIFIES ZOSANO PHARMA CORPORATION OF CLASS ACTION AND ENCOURAGES SHAREHOLDERS TO CONTACT THE FIRM
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-02 09:45:00
| null |
LOS ANGELES--(BUSINESS WIRE)---- $ZSAN #ZSAN--SHAREHOLDER ACTION REMINDER: THE SCHALL LAW FIRM ANNOUNCES THE FILING OF A CLASS ACTION LAWSUIT AGAINST ZOSANO PHARMA CORPORATION.
|
SHAREHOLDER ACTION REMINDER: THE SCHALL LAW FIRM ANNOUNCES THE FILING OF A CLASS ACTION LAWSUIT AGAINST ZOSANO PHARMA CORPORATION AND ENCOURAGES INVESTORS WITH LOSSES IN EXCESS OF $100,000 TO CONTACT THE FIRM
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-10-30 20:00:00
| null |
NEW YORK--(BUSINESS WIRE)-- #ZOSANO--BRAGAR EAGEL & SQUIRE, P.C., A NATIONALLY RECOGNIZED SHAREHOLDER RIGHTS LAW FIRM, ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF CALIFORNIA ON BEHALF OF INVESTORS THAT PURCHASED ZOSANO PHARMA CORP. (NASDAQ: ZSAN) SECURITIES BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020 (THE “CLASS PERIOD”). INVESTORS HAVE UNTIL DECEMBER 28, 2020 TO APPLY TO THE COURT TO BE APPOINTED AS LEAD PLAINTIFF IN THE
|
ZOSANO ALERT: BRAGAR EAGEL & SQUIRE, P.C. ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST ZOSANO PHARMA CORP. AND ENCOURAGES INVESTORS TO CONTACT THE FIRM
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-10-30 19:51:00
| null |
LOS ANGELES--(BUSINESS WIRE)---- $ZSAN #ZSAN--SHAREHOLDER ACTION ALERT: THE SCHALL LAW FIRM ANNOUNCES THE FILING OF A CLASS ACTION LAWSUIT AGAINST ZOSANO PHARMA CORPORATION.
|
SHAREHOLDER ACTION ALERT: THE SCHALL LAW FIRM ANNOUNCES THE FILING OF A CLASS ACTION LAWSUIT AGAINST ZOSANO PHARMA CORPORATION AND ENCOURAGES INVESTORS WITH LOSSES IN EXCESS OF $100,000 TO CONTACT THE FIRM
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-10-30 18:50:00
| null |
NEW YORK--(BUSINESS WIRE)--ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, ANNOUNCES THE FILING OF A CLASS ACTION LAWSUIT ON BEHALF OF PURCHASERS OF THE SECURITIES OF ZOSANO PHARMA CORPORATION (NASDAQ: ZSAN) BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020, INCLUSIVE (THE “CLASS PERIOD”). THE LAWSUIT SEEKS TO RECOVER DAMAGES FOR ZOSANO INVESTORS UNDER THE FEDERAL SECURITIES LAWS. TO JOIN THE ZOSANO CLASS ACTION, GO TO HTTP://WWW.ROSENLEGAL.COM/CASES-REGISTER-1963.HTML OR CALL PHILLIP KIM, ES
|
ROSEN, A TOP RANKED LAW FIRM, ANNOUNCES FILING OF SECURITIES CLASS ACTION LAWSUIT AGAINST ZOSANO PHARMA CORPORATION – ZSAN
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-10-30 11:00:00
| null |
LOS ANGELES--(BUSINESS WIRE)---- $ZSAN #CLASSACTION--THE LAW OFFICES OF FRANK R. CRUZ ANNOUNCES THAT IT HAS FILED A CLASS ACTION LAWSUIT IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA CAPTIONED CARR V. ZOSANO PHARMA CORPORATION, ET AL., (CASE NO. 3:20-CV-07625) ON BEHALF OF PERSONS AND ENTITIES THAT PURCHASED OR OTHERWISE ACQUIRED ZOSANO PHARMA CORPORATION (“ZOSANO” OR THE “COMPANY”)(NASDAQ: ZSAN) SECURITIES BETWEEN FEBRUARY 13, 2017 AND SEPTEMBER 30, 2020, INCLUSIVE (THE “CLASS PERIOD”).
|
ZSAN CLASS ACTION NOTICE: THE LAW OFFICES OF FRANK R. CRUZ FILES SECURITIES FRAUD LAWSUIT AGAINST ZOSANO PHARMA CORPORATION
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-10-29 19:51:00
| null |
LOS ANGELES--(BUSINESS WIRE)---- $ZSAN #CLASSACTION--ZSAN CLASS ACTION NOTICE: GLANCY PRONGAY & MURRAY LLP FILES SECURITIES FRAUD LAWSUIT AGAINST ZOSANO PHARMA CORPORATION
|
ZSAN CLASS ACTION NOTICE: GLANCY PRONGAY & MURRAY LLP FILES SECURITIES FRAUD LAWSUIT AGAINST ZOSANO PHARMA CORPORATION
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-09-30 20:30:00
| null |
ZOSANO PHARMA CORP - ON SEPT 29, RECEIVED DISCIPLINE REVIEW LETTER FROM U.S. FDA IN CONNECTION WITH QTRYPTA NEW DRUG APPLICATION.ZOSANO PHARMA CORP - DRL DESCRIBED TWO CONCERNS WITH RESPECT TO CLINICAL PHARMACOLOGY SECTION OF NDA.ZOSANO PHARMA CORP - FDA RAISED QUESTIONS REGARDING UNEXPECTED HIGH PLASMA CONCENTRATIONS OF ZOLMITRIPTAN OBSERVED IN 5 STUDY SUBJECTS.ZOSANO PHARMA - FDA RAISED QUESTIONS REGARDING DIFFERENCES IN ZOLMITRIPTAN EXPOSURES OBSERVED BETWEEN SUBJECTS RECEIVING DIFFERENT LOTS OF QTRYPTA.ZOSANO PHARMA CORP - APPROVAL OF QTRYPTA BY PRESCRIPTION DRUG USER FEE ACT GOAL DATE OF OCTOBER 20, 2020 IS NOT EXPECTED.
|
ZOSANO PHARMA RECEIVES DISCIPLINE REVIEW LETTER FROM U.S. FDA
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-08-31 18:30:00
| null |
ZOSANO PHARMA ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.
|
ZOSANO PHARMA ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-08-06 19:30:00
| null |
ZOSANO PHARMA ANNOUNCES PARTNERSHIP AGREEMENT WITH EVERSANA TO SUPPORT THE LAUNCH AND COMMERCIALIZATION OF QTRYPTA™.EVERSANA TO PROVIDE COMMERCIAL SERVICES OF APPROXIMATELY $250 MILLION OVER 5 YEARS.AGREEMENT OUTLINES COMMERCIALIZATION AND DISTRIBUTION EXECUTION STRATEGY UPON FDA APPROVAL.TERM OF AGREEMENT IS FIVE YEARS FOLLOWING DATE OF FDA APPROVA.
|
ZOSANO PHARMA ANNOUNCES PARTNERSHIP AGREEMENT WITH EVERSANA
|
ZSAN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.